share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

諾瓦瓦克斯醫藥 | 4：持股變動聲明-高管 Trizzino John

SEC announcement ·  03/12 09:43
牛牛AI助理已提取核心訊息
On March 7, 2024, John Trizzino, EVP, CCO, and CBO of Novavax Inc, completed a stock transaction involving the company's common stock. Trizzino exercised options to acquire 28,890 shares of Novavax common stock. On the same day, he sold 13,955 shares at a price of $5.61 per share, resulting in a total market value of $78,287.55 for the disposed shares. Following these transactions, Trizzino's direct holdings in Novavax amounted to 25,590 shares.
On March 7, 2024, John Trizzino, EVP, CCO, and CBO of Novavax Inc, completed a stock transaction involving the company's common stock. Trizzino exercised options to acquire 28,890 shares of Novavax common stock. On the same day, he sold 13,955 shares at a price of $5.61 per share, resulting in a total market value of $78,287.55 for the disposed shares. Following these transactions, Trizzino's direct holdings in Novavax amounted to 25,590 shares.
2024年3月7日，Novavax Inc執行副總裁、首席財務官兼首席運營官約翰·特里齊諾完成了一項涉及該公司普通股的股票交易。Trizzino行使期權收購了28,890股Novavax普通股。同一天，他以每股5.61美元的價格出售了13,955股股票，使處置股票的總市值達到78,287.55美元。這些交易之後，Trizzino在Novavax的直接持股量爲25,590股。
2024年3月7日，Novavax Inc執行副總裁、首席財務官兼首席運營官約翰·特里齊諾完成了一項涉及該公司普通股的股票交易。Trizzino行使期權收購了28,890股Novavax普通股。同一天，他以每股5.61美元的價格出售了13,955股股票，使處置股票的總市值達到78,287.55美元。這些交易之後，Trizzino在Novavax的直接持股量爲25,590股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。